Rein Therapeutics

RNTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$69.928 M

$0.82 +3.68%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$49.9M

Loss-making

Shares outstanding

28,039,032

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#330iBioIBIO$70.0M
#331Citius OncologyCTOR$70.0M
#332Rein TherapeuticsRNTX$69.9M
#333XBiotechXBIT$69.2M
#334Inovio PharmaceuticalsINO$69.0M

Where these numbers come from

Share counts and financials for Rein Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.